Davide Del Roscio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Davide Del Roscio has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Maria Antonietta Mazzei
Diagnostic Imaging Unit, Department of Medical Sciences, Azienda Ospedaliero Universitaria Senese, 53100 Siena, Italy
2 shared publications - Susanna Guerrini
Diagnostic Imaging Unit, Department of Medicine, Surgery and Neurosciences, Azienda Ospedaliero-Universitaria Senese, University of Siena, 53100 Siena, Italy
2 shared publications - Elena Bargagli
University of Siena
1 shared publication - Francesco Gentili
Department of Medicine and Surgery, Section of Radiology, Azienda Ospedaliera Universitaria di Parma, Parma, Italy
1 shared publication - Francesco Giuseppe Mazzei
Unit of Diagnostic Imaging, Department of Emergency-Urgency, Azienda Ospedaliero-Universitaria Senese, Siena, Italy
1 shared publication - Ilaria Monteleone
Unit of Diagnostic Imaging, Department of Medical, Surgical and Neuro Sciences and of Radiological Sciences, University of Siena, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy
1 shared publication
Latest Publications
- Open Access
- 21 February 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (4) , 2460
Lung Cancer Imaging: Screening Result and Nodule Management
Background: Lung cancer (LC) represents the main cause of cancer-related deaths worldwide, especially because the majority of patients present with an advanced stage of the disease at the time of diagnosis. This systematic review describes the evidence behind screening results and the current guidelines available to manage lung nodules. Methods: This review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The following electronic databases were searched: PubMed, EMBASE, and the Web of Science. Results: Five studies were included in the systematic review. The study cohort included 46,364 patients, and, in this case series, LC was detected in 9028 patients. Among the patients with detected LC, 1261 died of lung cancer, 3153 died of other types of cancers and 4614 died of other causes. Conclusions: This systematic review validates the use of CT in LC screening follow-ups, and bids for future integration and implementation of nodule management protocols to improve LC screening, avoid missed cancers and to reduce the number of unnecessary investigations.
- 21 February 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (4) , 2460
Open AccessLung Cancer Imaging: Screening Result and Nodule Management
Background: Lung cancer (LC) represents the main cause of cancer-related deaths worldwide, especially because the majority of patients present with an advanced stage of the disease at the time of diagnosis. This systematic review describes the evidence behind screening results and the current guidelines available to manage lung nodules. Methods: This review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The following electronic databases were searched: PubMed, EMBASE, and the Web of Science. Results: Five studies were included in the systematic review. The study cohort included 46,364 patients, and, in this case series, LC was detected in 9028 patients. Among the patients with detected LC, 1261 died of lung cancer, 3153 died of other types of cancers and 4614 died of other causes. Conclusions: This systematic review validates the use of CT in LC screening follow-ups, and bids for future integration and implementation of nodule management protocols to improve LC screening, avoid missed cancers and to reduce the number of unnecessary investigations.
- Open Access
Advancement in Diagnostic Imaging of Thymic Tumors
Thymic tumors are rare neoplasms even if they are the most common primary neoplasm of the anterior mediastinum. In the era of advanced imaging modalities, such as functional MRI, dual-energy CT, perfusion CT and radiomics, it is possible to improve characterization of thymic epithelial tumors and other mediastinal tumors, assessment of tumor invasion into adjacent structures and detection of secondary lymph nodes and metastases. This review aims to illustrate the actual state of the art in diagnostic imaging of thymic lesions, describing imaging findings of thymoma and differential diagnosis.
Open AccessAdvancement in Diagnostic Imaging of Thymic Tumors
Thymic tumors are rare neoplasms even if they are the most common primary neoplasm of the anterior mediastinum. In the era of advanced imaging modalities, such as functional MRI, dual-energy CT, perfusion CT and radiomics, it is possible to improve characterization of thymic epithelial tumors and other mediastinal tumors, assessment of tumor invasion into adjacent structures and detection of secondary lymph nodes and metastases. This review aims to illustrate the actual state of the art in diagnostic imaging of thymic lesions, describing imaging findings of thymoma and differential diagnosis.